Literature DB >> 18510533

Progress in the molecular biology of inherited bleeding disorders.

S W Pipe1, K A High, K Ohashi, A U Ural, D Lillicrap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18510533     DOI： 10.1111/j.1365-2516.2008.01718.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  9 in total

Review 1.  Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Authors:  Rajan Swami; Aliasgar Shahiwala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-14       Impact factor: 2.441

2.  Functional factor VIII made with von Willebrand factor at high levels in transgenic milk.

Authors:  S W Pipe; H Miao; S P Butler; J Calcaterra; W H Velander
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

Review 3.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

4.  Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector.

Authors:  Ali Ramezani; Robert G Hawley
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

Review 5.  Novel therapies and current clinical progress in hemophilia A.

Authors:  Pauline Balkaransingh; Guy Young
Journal:  Ther Adv Hematol       Date:  2017-12-28

6.  Genetically modified adipose tissue-derived stem/stromal cells, using simian immunodeficiency virus-based lentiviral vectors, in the treatment of hemophilia B.

Authors:  Natsumi Watanabe; Kazuo Ohashi; Kohei Tatsumi; Rie Utoh; In Kyong Shim; Kazuko Kanegae; Yuji Kashiwakura; Tsukasa Ohmori; Yoichi Sakata; Makoto Inoue; Mamoru Hasegawa; Teruo Okano
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

7.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

8.  Treatment of hemophilia: a review of current advances and ongoing issues.

Authors:  Antonio Coppola; Mirko Di Capua; Matteo Nicola Dario Di Minno; Mariagiovanna Di Palo; Emiliana Marrone; Paola Ieranò; Claudia Arturo; Antonella Tufano; Anna Maria Cerbone
Journal:  J Blood Med       Date:  2010-08-30

Review 9.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.